Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Assets (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Current Assets for 16 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 37.7% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2025, down 37.7%, and an annual FY2024 reading of $3.3 million, down 45.47% over the prior year.
  • Current Assets was $2.3 million for Q3 2025 at China Pharma Holdings, down from $2.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $9.1 million in Q4 2021 and bottomed at $2.3 million in Q3 2025.
  • Average Current Assets over 5 years is $5.1 million, with a median of $5.3 million recorded in 2021.
  • The sharpest move saw Current Assets soared 70.87% in 2021, then tumbled 45.47% in 2024.
  • Year by year, Current Assets stood at $9.1 million in 2021, then plummeted by 34.41% to $6.0 million in 2022, then rose by 0.54% to $6.0 million in 2023, then tumbled by 45.47% to $3.3 million in 2024, then decreased by 28.77% to $2.3 million in 2025.
  • Business Quant data shows Current Assets for CPHI at $2.3 million in Q3 2025, $2.7 million in Q2 2025, and $2.9 million in Q1 2025.